Faculty Opinions recommendation of RESPIRE 1: a phase III placebo controlled randomised trial of ciprofloxacin dry powder for inhalation in non cystic fibrosis bronchiectasis.
Faculty Opinions Post Publication Peer Review of the Biomedical Literature